Silverfin false false 31/05/2025 01/06/2024 31/05/2025 R F Facchiano 04/05/2012 M A Mohson 30/11/2012 25 February 2026 The principal activity of the company in the year under review was that of providing temporary medical staff. 08058862 2025-05-31 08058862 bus:Director1 2025-05-31 08058862 bus:Director2 2025-05-31 08058862 2024-05-31 08058862 core:CurrentFinancialInstruments 2025-05-31 08058862 core:CurrentFinancialInstruments 2024-05-31 08058862 core:ShareCapital 2025-05-31 08058862 core:ShareCapital 2024-05-31 08058862 core:SharePremium 2025-05-31 08058862 core:SharePremium 2024-05-31 08058862 core:RetainedEarningsAccumulatedLosses 2025-05-31 08058862 core:RetainedEarningsAccumulatedLosses 2024-05-31 08058862 core:LeaseholdImprovements 2024-05-31 08058862 core:Vehicles 2024-05-31 08058862 core:FurnitureFittings 2024-05-31 08058862 core:ComputerEquipment 2024-05-31 08058862 core:LeaseholdImprovements 2025-05-31 08058862 core:Vehicles 2025-05-31 08058862 core:FurnitureFittings 2025-05-31 08058862 core:ComputerEquipment 2025-05-31 08058862 core:CurrentFinancialInstruments 1 2025-05-31 08058862 core:CurrentFinancialInstruments 1 2024-05-31 08058862 bus:OrdinaryShareClass1 2025-05-31 08058862 bus:OrdinaryShareClass2 2025-05-31 08058862 2024-06-01 2025-05-31 08058862 bus:FilletedAccounts 2024-06-01 2025-05-31 08058862 bus:SmallEntities 2024-06-01 2025-05-31 08058862 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 08058862 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 08058862 bus:Director1 2024-06-01 2025-05-31 08058862 bus:Director2 2024-06-01 2025-05-31 08058862 core:LeaseholdImprovements 2024-06-01 2025-05-31 08058862 core:Vehicles 2024-06-01 2025-05-31 08058862 core:FurnitureFittings 2024-06-01 2025-05-31 08058862 core:ComputerEquipment 2024-06-01 2025-05-31 08058862 2023-05-31 2024-05-31 08058862 bus:OrdinaryShareClass1 2024-06-01 2025-05-31 08058862 bus:OrdinaryShareClass1 2023-05-31 2024-05-31 08058862 bus:OrdinaryShareClass2 2024-06-01 2025-05-31 08058862 bus:OrdinaryShareClass2 2023-05-31 2024-05-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 08058862 (England and Wales)

# RM MEDICS LTD

### Unaudited Financial Statements
For the financial year ended 31 May 2025
Pages for filing with the registrar

RM MEDICS LTD

## Unaudited Financial Statements

For the financial year ended 31 May 2025

Contents

RM MEDICS LTD

## COMPANY INFORMATION

For the financial year ended 31 May 2025
RM MEDICS LTD

## COMPANY INFORMATION (continued)

For the financial year ended 31 May 2025

DIRECTORS | R F Facchiano
| M A Mohson

REGISTERED OFFICE | Suite D1a
| Emerald Court Pilgrim Centre
| Brickhill Drive
| Bedford
| MK41 7PZ
| United Kingdom

COMPANY NUMBER | 08058862 (England and Wales)

ACCOUNTANT | Gravita Business Services II Limited
| Aldgate Tower
| 2 Leman Street
| London
| E1 8FA
| United Kingdom

RM MEDICS LTD

## STATEMENT OF FINANCIAL POSITION

As at 31 May 2025
RM MEDICS LTD

## STATEMENT OF FINANCIAL POSITION (continued)

As at 31 May 2025

| Note | 31.05.2025 |  | 31.05.2024
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 | 41,169 |  | 54,511
|  | 41,169 |  | 54,511
Current assets |  |  |  |
Debtors | 4 | 1,036,258 |  | 1,186,719
Cash at bank and in hand |  | 17,465 |  | 18,267
|  | 1,053,723 |  | 1,204,986
Creditors: amounts falling due within one year | 5 | ( 813,540) |  | ( 710,313)
Net current assets |  | 240,183 |  | 494,673
Total assets less current liabilities |  | 281,352 |  | 549,184
Net assets |  | 281,352 |  | 549,184
Capital and reserves |  |  |  |
Called-up share capital | 6 | 5 |  | 5
Share premium account |  | 7,433 |  | 7,433
Profit and loss account |  | 273,914 |  | 541,746
Total shareholders' funds |  | 281,352 |  | 549,184

For the financial year ending 31 May 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Comprehensive Income has not been delivered.

The financial statements of RM Medics Ltd (registered number: 08058862) were approved and authorised for issue by the Board of Directors on 25 February 2026. They were signed on its behalf by:

M A Mohson Director |

RM MEDICS LTD

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 May 2025
RM MEDICS LTD

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 May 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

##### General information and basis of accounting

RM Medics Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Suite D1a, Emerald Court Pilgrim Centre, Brickhill Drive, Bedford, MK41 7PZ, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

##### Turnover

Turnover is measured at the fair value of the consideration received pr receivable, excluding discount, rebates, value added tax and other sales taxes

##### Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Comprehensive Income in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Statement of Financial Position.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

##### Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements | 25 % reducing balance
Vehicles | 25 % reducing balance
Fixtures and fittings | 20 % reducing balance
Computer equipment | 33.33 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

##### Leases

The Company as lessee
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Statement of Comprehensive Income over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

##### Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Comprehensive Income as described below.

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Financial Assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

##### Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

#### 2. Employees

| Year ended 31.05.2025 |  | Period from 31.05.2023 to 31.05.2024
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including directors | 29 |  | 36

#### 3. Tangible assets

| Leasehold improve- ments |  | Vehicles |  | Fixtures and fittings |  | Computer equipment |  | Total
| £ |  | £ |  | £ |  | £ |  | £
Cost |  |  |  |  |  |  |  |  |
At 01 June 2024 | 55,868 |  | 29,560 |  | 113,767 |  | 198,898 |  | 398,093
Additions | 0 |  | 0 |  | 500 |  | 0 |  | 500
Disposals | 0 |  | ( 29,560) |  | 0 |  | 0 |  | ( 29,560)
At 31 May 2025 | 55,868 |  | 0 |  | 114,267 |  | 198,898 |  | 369,033
Accumulated depreciation |  |  |  |  |  |  |  |  |
At 01 June 2024 | 34,038 |  | 29,560 |  | 94,511 |  | 185,473 |  | 343,582
Charge for the financial year | 5,457 |  | 0 |  | 3,954 |  | 4,431 |  | 13,842
Disposals | 0 |  | ( 29,560) |  | 0 |  | 0 |  | ( 29,560)
At 31 May 2025 | 39,495 |  | 0 |  | 98,465 |  | 189,904 |  | 327,864
Net book value |  |  |  |  |  |  |  |  |
At 31 May 2025 | 16,373 |  | 0 |  | 15,802 |  | 8,994 |  | 41,169
At 31 May 2024 | 21,830 |  | 0 |  | 19,256 |  | 13,425 |  | 54,511

#### 4. Debtors

| 31.05.2025 |  | 31.05.2024
| £ |  | £
Trade debtors | 822,202 |  | 942,644
Amounts owed by directors | 8,717 |  | 0
Prepayments | 179,310 |  | 237,955
Corporation tax | 24,108 |  | 0
Other debtors | 1,921 |  | 6,120
| 1,036,258 |  | 1,186,719

#### 5. Creditors: amounts falling due within one year

| 31.05.2025 |  | 31.05.2024
| £ |  | £
Bank overdrafts | 482,599 |  | 272,814
Trade creditors | 63,979 |  | 49,481
Amounts owed to Group undertakings | 0 |  | 15,095
Amounts owed to connected companies | 15,095 |  | 0
Taxation and social security | 112,326 |  | 187,895
Other creditors | 139,541 |  | 185,028
| 813,540 |  | 710,313

#### 6. Called-up share capital

| 31.05.2025 |  | 31.05.2024
| £ |  | £
Allotted, called-up and fully-paid |  |  |
4 Ordinary shares of £ 1.00 each | 4 |  | 4
1 Ordinary A share of £ 1.00 | 1 |  | 1
| 5 |  | 5

#### 7. Related party transactions

Transactions with the entity's directors

| 31.05.2025 |  | 31.05.2024
| £ |  | £
Directors Loan Account | 8,067 |  | (3,112)

#### 8. Lease commitments

Minimum lease payments under non-cancellable operating leases fall due as follows:

| 31.05.2025 |  | 31.05.2024
| £ |  | £
Within one year | 23,925 |  | 60,308
Between one and four year | 38,485 |  | 109,142
| 62,410 |  | 169,450